I don't think so - that was from years ago when it was a miner...

I don't think so - that was from years ago when it was a miner wasn't it?

Top holders are Bluescan 10%, QIC 9%, private holder 5.3%, Biotech capital 4.9% a few others around 1-3% including some of the old Peregrine crowd (apparently escrowed) - now we add BioMira to to the mix. Announcment in April has top shareholders at the back.

Seriously - can anyone give me a good reason wht BioMira would switch its exposure to the parent?? There is more to this than meets the eye IMHO - I am guessing they want exposure to the DCtag sitting in the Panavax sub or the OncoMab stuff. Maybe they just want to take over PRR and the only way to get it is is the minority shareholders in the subsidiaries move into parent shareholdings. If we see the ARI agree to move its holdings into the parent then PRR officially becomes a T/O target - ie no blocking minority shareholders in the subsidiaries. I suspect the recent ARI directors resignation has something to do with this possibility.